Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-10-04 Purchase |
2022-10-06 08:30 am |
eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director |
346 | $0.57 | $197 | 178,415 (Indirect Direct) |
View |
| 2022-09-26 Purchase |
2022-09-27 08:01 am |
eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director |
18,867 | $0.55 | $10,377 | 178,069 (Indirect Direct) |
View |
| 2022-08-01 Sale |
2022-08-03 5:58 pm |
eFFECTOR Therapeutics Inc. | EFTR | Presidio Management Group X LLC US VENTURE PARTNERS X LP USVP X AFFILIATES LP Tansey Casey M ROOT JONATHAN D 10% Owner |
114,280 | $0.79807 | $91,203 | 127,569 (Indirect) |
View |
| 2022-07-28 Sale |
2022-07-29 8:54 pm |
eFFECTOR Therapeutics Inc. | EFTR | Presidio Management Group X LLC US VENTURE PARTNERS X LP USVP X AFFILIATES LP Tansey Casey M ROOT JONATHAN D 10% Owner |
32,517 | $0.892 | $29,005 | 131,025 (Indirect) |
View |
| 2022-07-25 Sale |
2022-07-27 6:20 pm |
eFFECTOR Therapeutics Inc. | EFTR | Presidio Management Group X LLC US VENTURE PARTNERS X LP USVP X AFFILIATES LP Tansey Casey M ROOT JONATHAN D 10% Owner |
48,719 | $0.89451 | $43,580 | 132,009 (Indirect) |
View |
| 2022-07-20 Sale |
2022-07-22 6:03 pm |
eFFECTOR Therapeutics Inc. | EFTR | Presidio Management Group X LLC US VENTURE PARTNERS X LP USVP X AFFILIATES LP Tansey Casey M ROOT JONATHAN D 10% Owner |
20,309 | $0.96086 | $19,514 | 133,483 (Indirect) |
View |
| 2022-07-15 Sale |
2022-07-19 4:54 pm |
eFFECTOR Therapeutics Inc. | EFTR | Presidio Management Group X LLC US VENTURE PARTNERS X LP USVP X AFFILIATES LP Tansey Casey M ROOT JONATHAN D 10% Owner |
69,641 | $1.0953 | $76,278 | 134,099 (Indirect) |
View |
| 2022-06-23 Purchase |
2022-06-27 06:00 am |
eFFECTOR Therapeutics Inc. | EFTR | Gallagher Brian M. Jr. Director |
30,000 | $1.59 | $47,700 | 30,000 (Direct) |
View |
| 2022-06-07 Purchase |
2022-06-09 06:00 am |
eFFECTOR Therapeutics Inc. | EFTR | WORLAND STEPHEN T President and Chief Executive |
20,000 | $1.37 | $27,400 | 777,317 (Indirect Direct) |
View |
| 2022-06-07 Purchase |
2022-06-07 5:30 pm |
eFFECTOR Therapeutics Inc. | EFTR | Byrnes Michael Chief Financial Officer |
25,000 | $1.3305 | $33,263 | 29,233 (Direct) |
View |
| 2022-05-17 Sale |
2022-05-19 6:16 pm |
eFFECTOR Therapeutics Inc. | EFTR | Presidio Management Group X LLC US VENTURE PARTNERS X LP USVP X AFFILIATES LP Tansey Casey M ROOT JONATHAN D 10% Owner |
34,427 | $1.7282 | $59,496 | 136,241 (Indirect) |
View |
| 2022-05-12 Sale |
2022-05-16 6:36 pm |
eFFECTOR Therapeutics Inc. | EFTR | Presidio Management Group X LLC US VENTURE PARTNERS X LP USVP X AFFILIATES LP Tansey Casey M ROOT JONATHAN D 10% Owner |
46,176 | $1.8516 | $85,501 | 137,309 (Indirect) |
View |
| 2022-05-09 Sale |
2022-05-11 8:10 pm |
eFFECTOR Therapeutics Inc. | EFTR | Presidio Management Group X LLC US VENTURE PARTNERS X LP USVP X AFFILIATES LP Tansey Casey M ROOT JONATHAN D 10% Owner |
48,984 | $2.4161 | $118,351 | 138,741 (Indirect) |
View |
| 2022-02-14 Purchase |
2022-02-22 4:59 pm |
eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director |
3,000 | $4.4 | $13,200 | 159,202 (Indirect Direct) |
View |
| 2022-02-08 Purchase |
2022-02-10 5:05 pm |
eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director |
2,000 | $4.835 | $9,670 | 156,202 (Indirect Direct) |
View |
| 2022-02-03 Purchase |
2022-02-07 09:00 am |
eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director |
6,000 | $5.125 | $30,750 | 154,202 (Indirect Direct) |
View |
| 2022-01-27 Purchase |
2022-01-31 5:50 pm |
eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director |
5,000 | $5.303 | $26,515 | 148,202 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-01-17 Option Award |
2023-01-19 5:02 pm |
N/A 2033-01-16 |
eFFECTOR Therapeutics Inc. | EFTR | Byrnes Michael Chief Financial Officer |
500,000 | $0 | 500,000 (Direct) |
View |
| 2022-11-15 Option Award |
2022-11-16 6:30 pm |
N/A N/A |
eFFECTOR Therapeutics Inc. | EFTR | Byrnes Michael Chief Financial Officer |
4,651 | $0.4684 | 33,884 (Direct) |
View |
| 2022-11-15 Option Award |
2022-11-16 6:27 pm |
N/A N/A |
eFFECTOR Therapeutics Inc. | EFTR | WORLAND STEPHEN T Chief Executive Officer |
6,047 | $0.4684 | 783,364 (Direct) |
View |
| 2022-09-26 Option Award |
2022-09-28 4:47 pm |
N/A 2032-09-25 |
eFFECTOR Therapeutics Inc. | EFTR | Gandhi Mayank Chief Business Officer |
500,000 | $0 | 500,000 (Direct) |
View |
Ownership |
2022-08-11 5:05 pm |
N/A N/A |
eFFECTOR Therapeutics Inc. | EFTR | Carlyle Group Inc. Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC 10% Owner |
0 | $0 | 5,435,229 (Indirect) |
View |
| 2022-08-08 Option Award |
2022-08-08 6:17 pm |
N/A 2032-08-07 |
eFFECTOR Therapeutics Inc. | EFTR | Warner Douglas J Chief Medical Officer |
618,160 | $0 | 618,160 (Direct) |
View |
| 2022-06-20 Option Award |
2022-06-22 4:19 pm |
N/A 2023-06-19 |
eFFECTOR Therapeutics Inc. | EFTR | McNulty Alana B. Chief Business Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2022-06-20 Option Award |
2022-06-22 4:17 pm |
N/A 2032-06-19 |
eFFECTOR Therapeutics Inc. | EFTR | Byrnes Michael Chief Financial Officer |
235,541 | $0 | 235,541 (Direct) |
View |
| 2022-06-20 Option Award |
2022-06-22 4:13 pm |
N/A 2032-06-19 |
eFFECTOR Therapeutics Inc. | EFTR | WORLAND STEPHEN T President and Chief Executive |
520,674 | $0 | 520,674 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 6:51 pm |
N/A 2032-06-08 |
eFFECTOR Therapeutics Inc. | EFTR | Smither John W Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 6:49 pm |
N/A 2032-06-08 |
eFFECTOR Therapeutics Inc. | EFTR | Klencke Barbara Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 6:46 pm |
N/A 2032-06-08 |
eFFECTOR Therapeutics Inc. | EFTR | Harrington-Smith Kristen Director |
13,333 | $0 | 13,333 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 6:44 pm |
N/A 2032-06-08 |
eFFECTOR Therapeutics Inc. | EFTR | Gallagher Brian M. Jr. Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 6:39 pm |
N/A 2032-06-08 |
eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 6:38 pm |
N/A 2032-06-08 |
eFFECTOR Therapeutics Inc. | EFTR | Bhatt Elizabeth Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-05-13 Option Award |
2022-05-17 8:46 pm |
N/A N/A |
eFFECTOR Therapeutics Inc. | EFTR | Byrnes Michael Chief Financial Officer |
4,233 | $1.53 | 4,233 (Direct) |
View |
| 2022-05-13 Option Award |
2022-05-17 8:44 pm |
N/A N/A |
eFFECTOR Therapeutics Inc. | EFTR | WORLAND STEPHEN T President and Chief Executive |
1,837 | $1.53 | 757,317 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 6:26 pm |
N/A 2032-02-14 |
eFFECTOR Therapeutics Inc. | EFTR | Harrington-Smith Kristen Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-24 8:11 pm |
N/A 2032-01-19 |
eFFECTOR Therapeutics Inc. | EFTR | Byrnes Michael Chief Financial Officer |
235,541 | $0 | 235,541 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-24 8:10 pm |
N/A 2032-01-19 |
eFFECTOR Therapeutics Inc. | EFTR | McNulty Alana B. Chief Business Officer |
150,000 | $0 | 150,000 (Direct) |
View |